Skip to main content
. 2017 Jun 21;14(2):2427–2431. doi: 10.3892/ol.2017.6435

Figure 2.

Figure 2.

Representative sequencing electropherograms of the potential mutation site in ERK2 p.E322, ERK1 p.E339, KRAS (p.G13 and p.Q61), NRAS (p.G12, p.G13 and p.Q61), HRAS (p.G12, p.G13 and p.Q61) and BRAF (p.V600E); the arrows refer to the wild type sequence with potential hotspot mutations. ERK, mitogen-activated protein kinase; KRAS, Kirsten rat sarcoma viral oncogene homolog; NRAS, neuroblastoma RAS; HRAS, Harvey RAS; BRAF, B-Raf proto-oncogene serine/threonine kinase.